1. Home
  2. FICO vs TEVA Comparison

FICO vs TEVA Comparison

Compare FICO & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fair Isaac Corproation

FICO

Fair Isaac Corproation

HOLD

Current Price

$923.69

Market Cap

34.7B

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$30.79

Market Cap

33.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FICO
TEVA
Founded
1956
1901
Country
United States
Israel
Employees
N/A
32842
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.7B
33.5B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
FICO
TEVA
Price
$923.69
$30.79
Analyst Decision
Buy
Strong Buy
Analyst Count
12
8
Target Price
$1,848.17
$38.63
AVG Volume (30 Days)
328.9K
5.6M
Earning Date
04-28-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
29.78
N/A
EPS
6.61
N/A
Revenue
$1,032,475,000.00
N/A
Revenue This Year
$27.28
N/A
Revenue Next Year
$17.01
$3.24
P/E Ratio
$162.08
$28.19
Revenue Growth
N/A
N/A
52 Week Low
$969.32
$13.04
52 Week High
$2,217.60
$37.35

Technical Indicators

Market Signals
Indicator
FICO
TEVA
Relative Strength Index (RSI) 28.68 52.79
Support Level N/A $30.70
Resistance Level $1,829.71 $31.99
Average True Range (ATR) 55.88 0.95
MACD 3.95 0.31
Stochastic Oscillator 6.09 82.51

Price Performance

Historical Comparison
FICO
TEVA

About FICO Fair Isaac Corproation

Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: